Avadel seeks to have its sodium oxybate agent be the first once-nightly therapy to address both excessive daytime sleepiness and cataplexy in patients with narcolepsy.
from Front page feed https://ift.tt/3di8opf
from Front page feed https://ift.tt/3di8opf
Comments
Post a Comment